Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

DoD Awards $450M Contract for Coronavirus Antibody Manufacturing

by Global Biodefense Staff
July 8, 2020

Advanced Technology International (ATI) is a nonprofit who builds and manages collaborations that conduct research and develop new technologies to solve the nation’s most pressing challenges. ATI is the consortium manager for two JPEO-CBRND consortia.

Advanced Technology International, Summerville, South Carolina, was awarded a $450,392,000 modification (P00074) to contract W15QKN-16-9-1002 for large-scale manufacturing of antibodies directed to novel coronavirus.

Work will be performed in Summerville, South Carolina; and Tarrytown, New York, with an estimated completion date of June 30, 2021. Fiscal 2020 research, development, test, and evaluation, Army, funds in the amount of $450,392,000 were obligated at the time of the award.

U.S. Army Contracting Command, Newark, New Jersey, is the contracting activity.

Source: Defense.gov

Tags: AwardsCoronavirusCOVID-19

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC